Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal neostigmine added to bupivacaine for postoperative pain after lower limb orthopedic surgery
ACTRN12613000908730Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neostigmine and bupivacaine in postoperative pain (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Time to first requirement of analgesic supplement, Duration of sensory block and 1 more. Started Aug 2013; status: completed.
02
Drugs
neostigminebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12613000908730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000908730.